SPECIFICITY OF PEPTIDE BINDING BY THE HLA-A2.1 MOLECULE

被引:0
|
作者
SHIMOJO, N [1 ]
MALOY, WL [1 ]
ANDERSON, RW [1 ]
BIDDISON, WE [1 ]
COLIGAN, JE [1 ]
机构
[1] NIAID,BIOL RESOURCES BRANCH,BETHESDA,MD 20892
来源
JOURNAL OF IMMUNOLOGY | 1989年 / 143卷 / 09期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2939 / 2947
页数:9
相关论文
共 50 条
  • [1] PROMINENT ROLE OF SECONDARY ANCHOR RESIDUES IN PEPTIDE BINDING TO HLA-A2.1 MOLECULES
    RUPPERT, J
    SIDNEY, J
    CELIS, E
    KUBO, RT
    GREY, HM
    SETTE, A
    [J]. CELL, 1993, 74 (05) : 929 - 937
  • [2] Docking studies of peptide/HLA-A2.1 complexes.
    Kucukkal, TG
    Meng, WS
    Evanseck, JD
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U446 - U446
  • [3] Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling
    Lim, JS
    Kim, S
    Lee, HG
    Lee, KY
    Kwon, TJ
    Kim, K
    [J]. MOLECULAR IMMUNOLOGY, 1996, 33 (02) : 221 - 230
  • [4] ISOLATION OF AN HLA-A2.1 EXTRACTED HUMAN MINOR HISTOCOMPATIBILITY PEPTIDE
    DEBUEGER, M
    VERRECK, F
    BLOKLAND, E
    DRIJFHOUT, JW
    AMONS, R
    KONING, F
    GOULMY, E
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) : 614 - 618
  • [5] A recombinant single-chain HLA-A2.1 molecule, with a cis active beta-2-microglobulin domain, is biologically active in peptide binding and antigen presentation
    Lee, L
    Loftus, D
    Appella, E
    Margulies, DH
    Mage, M
    [J]. HUMAN IMMUNOLOGY, 1996, 49 (01) : 28 - 37
  • [6] EXPRESSION AND FUNCTION OF HLA-A2.1 IN TRANSGENIC MICE
    EPSTEIN, H
    HARDY, R
    MAY, JS
    JOHNSON, MH
    HOLMES, N
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (09) : 1575 - 1583
  • [7] MULTIPLE SHARED HLA-A2.1 ASSOCIATED PEPTIDE EPITOPES FOR MELANOMA-SPECIFIC CTL
    SLINGLUFF, CL
    COX, AL
    HENDERSON, RA
    HUNT, DF
    ENGELHARD, VH
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 112 - 112
  • [8] CYTO-TOXIC T-CELL RESPONSES IN HLA-A2.1 TRANSGENIC MICE - RECOGNITION OF HLA ALLOANTIGENS AND UTILIZATION OF HLA-A2.1 AS A RESTRICTION ELEMENT
    LE, AXT
    BERNHARD, EJ
    HOLTERMAN, MJ
    STRUB, S
    PARHAM, P
    LACY, E
    ENGELHARD, VH
    [J]. JOURNAL OF IMMUNOLOGY, 1989, 142 (04): : 1366 - 1371
  • [9] Candidate cancer vaccines: Oncogenic mutations in RAS create HLA-A2.1 binding peptides
    Smith, MC
    Pendleton, CD
    Kelley, MJ
    Carbone, DP
    Berzofsky, JA
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A247 - A247
  • [10] SIGNIFICANCE OF THE 6 PEPTIDE-BINDING POCKETS OF HLA-A2.1 IN INFLUENZA-A MATRIX PEPTIDE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE REACTIVITY
    MATSUI, M
    MOOTS, RJ
    MCMICHAEL, AJ
    FRELINGER, JA
    [J]. HUMAN IMMUNOLOGY, 1994, 41 (02) : 160 - 166